Enfin disponible en France, grâce à une étonnante formule France, 100% naturelle, vous pouvez maintenant dire stop à vos problèmes d’impuissance et à vos troubles de la virilité. Cette formule révolutionnaire agit comme un véritable achat levitra naturel. Ses résultats sont immédiats, sans aucun effet secondaire et vos érections sont durables, quelque soit votre âge. Même si vous avez plus de 60 ans !

Microsoft word - pollak2006w _2_.doc

CURRICULUM VITAE
RICHARD A. POLLAK, DPM, MS

ADDRESS:

BIRTH DATE:

BIRTHPLACE:

MARITAL STATUS:

HIGH SCHOOL:

COLLEGE:


PROFESSIONAL:
California College of Podiatric Medicine Pennsylvania College of Podiatric Medicine
POSTGRADUATE
TRAINING:


LICENSING:

PRIVATE PRACTICE: San Antonio, Texas
1979- present
CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 2
CERTIFICATION:

Diplomate, American Board of Podiatric Surgery Fellow, American College of Foot Surgeons 1983
TEACHING
APPOINTMENTS:

Visiting Clinical Instructor, Pennsylvania College Podiatric Medicine, Department of Surgery
PROFESSIONAL
SOCIETIES
:

POSITIONS HELD:
American Academy of Wound Management (1998-1999) in the treatment of Diabetic Foot Ulcers Dermagraft™ Advisory Board (7/11-7/13/97) Sporonox™ Regional Advisory Board Janssen (5/29-31/98) Orthopedic Policy Committee South Texas Ambulatory Surgical Hospital San Antonio, Texas (1992-present) CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 3

Member, Oral Examination Committee American Board of Podiatric Surgery (1989 and 1992) Orthopedic Quality Assurance Committee St. Luke's Lutheran Hospital San Antonio, Texas (1991-1992) Medical Executive Committee Surgicenter San Antonio, Texas (1990-1992)

PUBLICATIONS
:
Safety of Oral Terbinafine for Toenail Onychomycosis, Journal of the American Podiatric Medical
Association, Vol. 87, No. 12, Dec 1997. Co-authored with Stephan A. Billstein, MD
A Human Dermal Replacement for the Treatment of Diabetic Foot Ulcers, WOUNDS: A Compendium of
Clinical Research and Practice, Vol. 9, No. 6, Nov/Dec 1997. Co-authored with Howard Edington, MD,
Jeffrey L. Jensen, DPM, Roy O. Kroeker, DPM, Gary D. Gentzkow, MD and the Dermagraft Diabetic Ulcer
Study Group
Risk of Complications of First Metatarsal Head Osteotomies with Biodegradable Pin Fixation: Bioflx versus
Orthosore, Journal of Foot Surgery, Jul/Aug 1994. Co-authored with Lawrence A. Lavery, DPM, Jon
Peterson, DPM, Kevin R.Higgins, DPM
Patient Expectations of Elective Foot Surgery, Journal of Foot Surgery, Nov/Dec 1993, 32:6, 580-583. C-
authored with Richard Bellacosa, DPM
Sonographic Analysis of Morton Neuroma, Journal of Foot Surgery, Nov/Dec, 1992, 31:6, 534-537. Co-
authored with Richard Bellacosa, DPM, Carol Dornbluth, M.D., Walter Strash, DPM, and Marshall Devall,
DPM
Rigid Plantarflexion of All Digits: A Surgical Correction, Journal of Foot Surgery, Jan/Feb 1992,31:1, 57-
62. Co-authored with Richard Bellacosa, DPM and Vincent Giacalone, DPM
Complications of Lesser Metatarsal Surgery Clinics in Podiatric Medicine and Surgery, Apr 1991, 8:2,383-
397. Co-authored with Richard Bellacosa, DPM
Critical Evaluation of the Short Bunionectomy, Journal of Foot Surgery, Mar/Apr 1989, 28:2, 151-161. Co-
authored with Richard Bellacosa, DPM, Kevin Higgins, DPM, Bert Sharp, DPM, and Thomas McCloskey,
DPM
Diabetic Foot Care: How a Podiatrist Can Help, Consultant, Feb. 15, 1985. Co-authored with Richard
Bellacosa, DPM
CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 4
CLINICAL RESEARCH EXPERIENCE

A Dose Response Evaluation of the Safety and Efficacy of a new medication in a Lyophilized Collagen
Sponge, for the Treatment of Chronic Neurotrophic, Foot Ulcers in Diabetics

A Prospective, Multi-Center, Randomized, Single Blind Clinical Investigation of an Investigational in
Patients with Plantar Diabetic Foot Ulcers
A Study of the Comparative Efficacy of an Investigational Topical Cream Vs. an Approved Antibiotic in the
Treatment of Infected Diabetic Ulcers.
An Open-Label, Multicenter Trial to Evaluate the Safety and Effectiveness of Various Treatment Durations of an Approved Oral Medication in Patients With Onychomycosis of the Toenails An Investigational Meddication Versus Standard Therapy in the Healing of Chronic, Lower Extremity Diabetic Ulcers A Randomized Clinical Evaluation of an Investigational Medication Versus Standard Therapy in the Healing of Chronic, Lower-Extremity Diabetic Ulcers An Open-Label, Non-Comparative, Multicenter Trial on the Use of an Oral Investigational Medication for the Treatment of Diabetic Foot Infections A Multi-Center Prospective Randomized Controlled Clinical Trial of an Investigational Medication for the Treatment of Diabetic Foot Ulcers A Double-Blind, Placebo Controlled Trial to Evaluate an Intermittent Dosage Regimen of an Investigational Medication in the Treatment of Distal Subungual Onychomycosis A Multicenter, Double-Blind Study to Evaluate the Safety and Efficacy of an Investigational Medication Cream in the Treatment of Tinea Pedis. A Prospective, Multicenter, Randomized, Single-Masked, Controlled, Clinical Investigation of an Investigational Medication in Patients with Plantar Diabetic Foot Ulcers A Multicenter, Double-Blind Study to Evaluate an Investigational Medication and Vehicle in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail Clinical Protocol for a Double-Blind, Placebo-Controlled Comparison of the Analgesic Activity of Pre-Operative Doses of Investigational Medication and Placebo in Post-Bunionectomy Surgery Clinical Protocol for a Double-Blind, Placebo and Active-Controlled Comparison of the Analgesic Activity of Investigational Medication, Approved Medication and Placebo In Post-Bunionectomy Surgical Patients Onychomycosis Patient Satisfaction Survey Comparing Mechanical Versus Oral Drug Therapy Among Patients Treated by Podiatrists CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 5

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Safety of
an Investigational Spray Powder in Subjects with Tinea Pedis

The Efficacy and Safety Evaluation of an Investigational Medication in the Treatment of Tinea Pedis
A Multicenter, Double-Blind, Randomized, Parallel Group, Two-Period Study to Evaluate the Efficacy and
Safety of Oral Doses of An Extended-Release Combination of an Investigational Medication and Placebo in
the Treatment of Moderate to Severe Pain in Subjects Undergoing Orthopedic Surgery
An Open-Label, Randomized, Study Comparing the Efficacy and Safety of an Approved Medication and an
Investigational Medication Administered Intravenously in the Empirical Treatment of Foot Infection in
Diabetic Inpatients
A Randomized, Multicenter, Investigator Blinded Study of the Efficacy and Safety of an Approved
Medication versus an Approved Medication in the Treatment of Uncomplicated Skin and Skin Structure
Infections of Bacterial Origin
A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Assess the Efficacy,
Safety and Tolerability of New Oral Formulation in Patients with Onychomycosis of the
Toenails
A Randomized, Open-Label, Multi-Center Trial to Investigate the Efficacy and Safety of 12 Weeks Oral
Approved Medication With and Without Nail Debridement In The Treatment of Onychomycosis
A Revised Clinical Protocol for a Randomized, Double-Blind, Placebo Controlled, Multiple Dose
Assessment of the Analgesic Efficacy of the Dosing Regimen of an Investigational Medication Compared to
Placebo Patients in Pain Following Bunionectomy
A Prospective, Multicenter, Double-Blind with In-House Blinding, Randomized, Comparative Study To
Evaluate the Efficacy, Safety, And Tolerability of an Approved Medication Versus an Approved Medication
In the Treatment of Diabetic Foot Infections in Adults
A Comparative, Prospective, Randomized, Double-Masked, Parallel Group, Controlled Trial of an
Investigational Device Therapy Versus Sham Control When Added to Standard of Care in the Treatment of
Diabetic Neuropathic Ulcers
A Double-Blind, Randomized, Vehicle-Controlled, Sequential-Dose-Escalation Study Assessing the Safety,
Clinical Pharmacology, Systemic Disposition, and Pharmocokinetics of an Investigational Gel Versus
Matching Vehicle Gel When Applied Topically to Subjects with Diabetic, Neuropathic, Foot Ulcers
CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 6

SPEAKING
ENGAGEMENTS:

Reshaping Physician Views Toward Onychomycosis “Office Management of Common Orthopedic Problems” San Antonio, Texas (10/16/98) Redefining Physicians’ views Towards Onychomycosis St. Louis, Missouri (10/27/98) Clinical Update on Lamisil Milwaukee, Wisconsin (10/28/98) and Kansas City, Missouri (10/29/98) Onychomycosis in the Diabetic and Elderly Patient Population Kansas City, Missouri (10/29/98) Reshaping Physicians’ Views Towards Onychomycosis Teleconference Supported by Novartis Apligraf® (Graftskin) Global Investigator’ Meeting on Diabetic Foot Ulcers and Graftskin (9/24/99 and 9/25/99) Onychomycosis – L.I.O.N. study results 1st Annual – February 3, 1990 (St. Lukes Lutheran Hospital) Office Management of Common Orthopaedic Problems Conference Injuries about the Forefoot 4th Annual – March 27, 1993 (St. Lukes Lutheran Hospital) Office Management of Common Orthopaedic Problems Conference Shoe Selection, Orthotics & Padding 7th Annual – August 2, 1997 (Baptist Health System) Office Management of Common Orthopaedic Problems Conference Podiatry’s Top Seven Problems 8th Annual – August 22, 1998 (Baptist Health System) Office Management of Common Orthopaedic Problems Conference Common Foot and Ankle Problems CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 7

9th Annual – February 5, 2000 (Baptist Health System) Office Management of Common Orthopaedic Problems Conference Common Foot Disorders Novartis Onychomycosis Clinical Learning Day Treatment of Onychomycosis Houston, Texas (3/14/00) Novartis Onychomycosis Clinical Learning Day Treatment of Onychomycosis Denver, Colorado (3/15/00) Novartis Onychomycosis Clinical Learning Day Treatment of Onychomycosis Las Vegas, Nevada (4/5/00) Lamaism Speakers Orientation Onychomycosis in the Diabetic Foot Phoenix, Arizona (4/14/00-4/16/00) Novartis Onychomycosis Clinical Learning Day Treatment of Onychomycosis Pueblo, Colorado (4/26/00) Novartis Onychomycosis Clinical Learning Day Treatment of Onychomycosis Dallas, Texas (4/27/00) Baptist Health System Orthopaedic Conference 2001 Foot Disorders San Antonio, Texas (02/17/01) Baptist Health System Wound Care Update Off-Loading Orthotics San Antonio, Texas (06/02/01) Novartis Issues with Onychomycosis New Haven, Connecticut (10/17/01) Novartis Issues with Onychomycosis Springfield, Massachusetts (10/18/01) Novartis Issues with Onychomycosis Newton, Massachusetts (10/19/01) Novartis Treatment of Onychomycosis Harlingen, Texas (2/8/02) CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 8

Novartis Treatment of Onychomycosis Corpus Christi, Texas (2/22/02) Novartis Treatment of Onychomycosis San Antonio, Texas (2/27/02) Novartis Treatment of Onychomycosis San Antonio, Texas (3/5/02) Novartis Treatment of Onychomycosis Tyler, Texas (3/6/02) Omnicef and Loprox San Antonio, Texas (3/7/02) Novartis Treatment of Onychomycosis Austin, Texas (4/11/02) GD Searle Dinner Meeting at Regiano’s Treatment of Osteoarthritis by Means of Valdecoxib San Antonio, Texas (4/17/02) Novartis Onychomycosis, Lamisil Discussion Dallas, Texas (4/18/02) Novartis Treatment of Onychomycosis Chicago, Illinois (4/24/02) Novartis Treatment of Onychomycosis Bandera, Texas (5/12/02) Novartis Treatment of Onychomycosis Stamford, CT (5/13/02) Novartis Treatment of Onychomycosis Hartford, CT (5/14/02) Novartis Treatment of Onychomycosis Springfield, MA (5/15/02) CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 9

Novartis Treatment of Onychomycosis Worcester, MA (5/16/02) Novartis Treatment of Onychomycosis Newport, RI (5/17/02) Novartis Treatment of Onychomycosis Quincy, MA (5/18/02) Novartis Treatment of Onychomycosis Amarillo, TX (6/18/02) Novartis Treatment of Onychomycosis Dallas, TX (6/19/02) Novartis Treatment of Onychomycosis Las Vegas, NV (6/22/02) Novartis Treatment of Onychomycosis Las Vegas, NV (6/24/02) Novartis Treatment of Onychomycosis Salt Lake City, UT (7/3/02) Novartis Treatment of Onychomycosis Reno, NV (7/25/02) Novartis Treatment of Onychomycosis Arlington, TX (8/14/02) Novartis Treatment of Onychomycosis Kansas City, KS (8/17/02) Novartis Treatment of Onychomycosis Birmingham, MI (8/28/02) Novartis Treatment of Onychomycosis Teleconferences (3/3/03, 3/4/03, 3/5/03, 3/10/03, 3/11/03, 3/12/03, 3/24/03, 3/25/03, CURRICULUM VITAE
RICHARD A. POLLAK, DPM, M.S.
Page 10

Novartis Treatment of Onychomycosis Fort Worth, TX (4/1/2003) Novartis Treatment of Onychomycosis Fort Worth, TX (4/15/2003) Novartis Onychomycosis – Need to Treat Houston, TX (3/4/2003) Novartis Onychomycosis – Need to Treat Salt Lake City, UT (3/17/2003 – 3/18/2003) Novartis Teleconferences Onychomycosis (6/16/03, 6/17/03, 6/19/03, 6/23/03, 6/24/03, 6/25/03, 7/8/03, 7/10/03) Novartis Onychomycosis Las Vegas, NV (7/29/2003 – 7/30/2003) Novartis Onychomycosis Reno, NV (7/31/03) Novartis Teleconferences Onychomycosis (8/27, 2003, 9/4/2003, 9/9/2003, 9/16/2003, 9/18/2003) Novartis Onychomycosis Troy, MI (9/23/2003-9/24/2003)

Source: http://www.sapodiatry.com/cv_pollak.pdf

Untitled

Úselo y tírelo La sociedad de consumo ofrece fugacidades. Cosas, personas; las cosas fabricadas para durar, mueren al nacer, y hay cada vez más personas arrojadas a la basura desde que se asoman a la vida. Los niños abandonados en las calles de Colombia, que antes se llamaban gamines y ahora se llaman desechables, y están marcados para morir. Los numerosos nadies, los fuera de lugar, son

Microsoft word - juicio contra union fenosa nicaragua.doc

EL JUICIO CONTRA UNION FENOSA Tribunal Permanente de los Pueblos San Cristóbal de las Casas, Chiapas, México; 23 de Octubre de 2007 El 12 y 13 de Octubre de 2007 el Tribunal Permanente de los Pueblos (TPP) sesionó en tres audiencias en Managua, Nicaragua, en torno al caso de los efectos que genera la privatización de la energía eléctrica, en este caso por la trasnacional español

Copyright © 2010-2014 Online pdf catalog